Trial Profile
Impact of bone metastases on overall survival in patients with metastatic renal cell cancer treated with sunitinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary) ; Axitinib; Everolimus; Pazopanib; Sorafenib; Temsirolimus
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record